Application of imiquimod and resiquimod in dermatology

Ke-Jian XU; Yue-Hua LIU

Application of imiquimod and resiquimod in dermatology / 中国医学科学院学报

Ke-Jian XU; Yue-Hua LIU.

Acta Academiae Medicinae Sinicae ; (6): 445-447, 2006.

Article in Chinese | WPRIM | ID: wpr-281177

ABSTRACT

ABSTRACT

Imiquimod (R-837) and Resiquimod (R-838), two novel small-molecular-weight immune response modifiers, have similar structure. They have anti-virus and anti-tumor activities and can be used as B lymphocyte activators and adjuvants. They are widely used in dermatology to treat virus dermatoses and cutaneous benign or malignant tumors.

Subject(s)

Humans; Adjuvants, Immunologic; Therapeutic Uses; Aminoquinolines; Therapeutic Uses; Antineoplastic Agents; Therapeutic Uses; Condylomata Acuminata; Drug Therapy; Imidazoles; Therapeutic Uses; Skin Neoplasms; Drug Therapy

Fulltext

XML

Search on Google

Full text: Available Index: WPRIM (Western Pacific) Main subject: Skin Neoplasms / Condylomata Acuminata / Adjuvants, Immunologic / Therapeutic Uses / Drug Therapy / Aminoquinolines / Imidazoles / Antineoplastic Agents Limits: Humans Language: Chinese Journal: Acta Academiae Medicinae Sinicae Year: 2006 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google